SGEN - Seattle Genetics Inc /wa - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - SGEN (1060736)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
81 results - Yahoo - Google - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

D
2020-05-15
SGENBaker Bros. Advisors LPDir, 10%S - Sale+OE$160.00-1,750,00043,653,644-4%-$280,000,000
D
2020-05-12
SGENRomp Charles REVP, CommercialS - Sale+OE$166.00-6,94252,575-12%-$1,152,372
D
2020-05-08
SGENSiegall Clay BPres, CEOS - Sale+OE$161.01-28,472718,339-4%-$4,584,311
D
2020-05-08
SGENRomp Charles REVP, CommercialS - Sale+OE$163.02-6,94252,575-12%-$1,131,667
D
2020-05-07
SGENDansey Roger DChief Medical OfficerS - Sale+OE$164.50-11,912117,233-9%-$1,959,526
M
2020-05-06
SGENBaker Bros. Advisors LPDir, 10%S - Sale$161.85-1,058,31645,254,621-2%-$171,290,420
M
2020-05-05
SGENWelch Daniel GDirS - Sale$165.90-35,00055,263-39%-$5,806,560
M
2020-05-05
SGENSiegall Clay BPres, CEOS - Sale$165.65-50,000718,339-7%-$8,282,403
2020-05-05
SGENRomp Charles REVP, CommercialS - Sale$166.18-5,05652,575-9%-$840,226
D
2020-05-05
SGENAkkaraju SrinivasDirS - Sale+OE$167.26-8,50040,168-17%-$1,421,710
DM
2020-05-04
SGENSimpson Todd ECFOS - Sale+OE$157.43-41,034173,888-19%-$6,460,152
2020-05-04
SGENLippman Marc EDirS - Sale$152.03-1,000130,313-1%-$152,030
D
2020-04-08
SGENSiegall Clay BPres, CEOS - Sale+OE$120.01-28,472758,784-4%-$3,416,814
D
2020-03-09
SGENSiegall Clay BPres, CEOS - Sale+OE$110.09-28,472758,784-4%-$3,134,578
D
2020-03-06
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$114.91-8,000188,674-4%-$919,292
2020-02-18
SGENDansey Roger DChief Medical OfficerS - Sale$116.33-350107,6590%-$40,716
D
2020-02-10
SGENSiegall Clay BPres, CEOS - Sale+OE$114.61-28,472758,784-4%-$3,263,110
2020-02-03
SGENDansey Roger DChief Medical OfficerS - Sale$108.51-727108,009-1%-$78,887
D
2020-01-08
SGENSiegall Clay BPres, CEOS - Sale+OE$111.32-28,472758,784-4%-$3,169,433
2019-12-16
SGENDansey Roger DChief Medical OfficerS - Sale$114.07-2,000101,146-2%-$228,140
D
2019-12-09
SGENSiegall Clay BPres, CEOS - Sale+OE$114.56-28,472755,684-4%-$3,261,641
D
2019-12-06
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$117.16-8,000187,518-4%-$937,265
D
2019-11-25
SGENDansey Roger DChief Medical OfficerS - Sale+OE$121.48-5,000103,146-5%-$607,388
D
2019-11-21
SGENAkkaraju SrinivasDirS - Sale+OE$119.78-17,50040,168-30%-$2,096,120
D
2019-11-18
SGENDansey Roger DChief Medical OfficerS - Sale+OE$116.00-5,000103,146-5%-$580,000
D
2019-11-18
SGENLippman Marc EDirS - Sale+OE$115.80-35,000131,313-21%-$4,053,000
D
2019-11-08
SGENSiegall Clay BPres, CEOS - Sale+OE$107.61-28,472755,684-4%-$3,063,816
D
2019-10-08
SGENSiegall Clay BPres, CEOS - Sale+OE$82.47-28,472755,684-4%-$2,348,061
D
2019-10-01
SGENGryska David WDirS - Sale+OE$85.09-5,00048,013-9%-$425,450
2019-09-30
SGENSimpson Todd ECFOS - Sale$85.00-15,000157,567-9%-$1,275,000
2019-09-30
SGENLiu Jean IGC, EVP, Leg AffairsS - Sale$86.00-7,43270,688-10%-$639,152
2019-09-25
SGENDansey Roger DChief Medical OfficerS - Sale$73.80-3,000103,146-3%-$221,415
D
2019-09-09
SGENSiegall Clay BPres, CEOS - Sale+OE$68.33-28,472755,684-4%-$1,945,531
D
2019-09-03
SGENSiegall Clay BSee RemarksS - Sale+OE$70.80-9,693755,684-1%-$686,257
DM
2019-08-30
SGENHimes Vaughn BSee RemarksS - Sale+OE$72.00-13,692187,518-7%-$985,849
D
2019-09-03
SGENDansey Roger DSee RemarksS - Sale+OE$70.80-922106,146-1%-$65,277
D
2019-09-03
SGENLiu Jean ISee RemarksS - Sale+OE$0.00-1,77978,120-2%-$0
D
2019-09-03
SGENSimpson Todd ESee RemarksS - Sale+OE$70.80-2,092172,567-1%-$148,112
2019-08-28
SGENSimpson Todd ECFOS - Sale$73.21-5,909153,371-4%-$432,624
2019-08-28
SGENSiegall Clay BPres, CEOS - Sale$73.21-28,951717,343-4%-$2,119,636
2019-08-28
SGENLiu Jean IGC, EVP, Leg AffairsS - Sale$73.22-6,01360,904-9%-$440,242
2019-08-28
SGENHimes Vaughn BChief Technical OfficerS - Sale$73.21-6,836175,197-4%-$500,496
2019-08-20
SGENSimpson Todd ECFOS - Sale$80.00-12,500159,280-7%-$1,000,000
2019-08-20
SGENLiu Jean IGC, EVP, Leg AffairsS - Sale$80.00-3,71666,917-5%-$297,280
D
2019-08-08
SGENSiegall Clay BPres, CEOS - Sale+OE$76.52-20,149746,294-3%-$1,541,827
2019-08-06
SGENLiu Jean IGC, EVP, Leg AffairsS - Sale$75.00-3,71670,633-5%-$278,700
D
2019-07-17
SGENGryska David WDirS - Sale+OE$75.00-5,00048,013-9%-$375,000
D
2019-07-08
SGENSiegall Clay BPres, CEOS - Sale+OE$66.89-20,148746,294-3%-$1,347,664
2019-06-17
SGENDansey Roger DChief Medical OfficerS - Sale$68.60-5,41677,593-7%-$371,538
D
2019-06-10
SGENSiegall Clay BPres, CEOS - Sale+OE$69.05-20,148746,294-3%-$1,391,175
D
2019-05-31
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$65.94-8,000177,329-4%-$527,485
DM
2019-05-08
SGENSiegall Clay BPres, CEOS - Sale+OE$68.06-20,148749,169-3%-$1,371,367
D
2019-04-08
SGENSiegall Clay BPres, CEOS - Sale+OE$79.22-20,148749,169-3%-$1,596,100
2019-04-05
SGENSimpson Todd ECFOS - Sale$78.00-12,500171,780-7%-$975,000
D
2019-04-01
SGENGryska David WDirS - Sale+OE$73.41-5,00045,050-10%-$367,030
D
2019-03-08
SGENSiegall Clay BPres, CEOS - Sale+OE$69.19-20,148732,613-3%-$1,394,094
D
2019-03-08
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$68.72-8,000177,329-4%-$549,746
2019-03-04
SGENSimpson Todd ECFOS - Sale$75.00-10,000184,280-5%-$750,000
D
2019-02-08
SGENSiegall Clay BSee RemarksS - Sale+OE$65.17-20,148732,613-3%-$1,313,126
D
2019-01-08
SGENGryska David WDirS - Sale+OE$65.04-5,00045,050-10%-$325,200
D
2019-01-08
SGENSiegall Clay BPres, CEOS - Sale+OE$65.73-20,148732,613-3%-$1,324,237
D
2018-12-10
SGENSiegall Clay BPres, CEOS - Sale+OE$59.74-20,148732,613-3%-$1,203,545
D
2018-11-30
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$62.14-5,000177,329-3%-$310,718
2018-11-29
SGENCline Darren SEVP, CommercialS - Sale$62.88-7,00072,556-9%-$440,160
2018-11-21
SGENCline Darren SEVP, CommercialS - Sale$56.68-4,16779,556-5%-$236,204
D
2018-11-08
SGENSiegall Clay BPres, CEOS - Sale+OE$61.54-20,148732,613-3%-$1,239,873
D
2018-10-08
SGENSiegall Clay BPres, CEOS - Sale+OE$77.39-20,148732,613-3%-$1,559,231
D
2018-09-17
SGENSiegall Clay BPres, CEOS - Sale+OE$76.84-20,148732,613-3%-$1,548,196
D
2018-09-07
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$76.99-5,000177,329-3%-$384,962
2018-08-27
SGENSimpson Todd ECFOS - Sale$74.23-5,427173,565-3%-$402,856
2018-08-27
SGENSiegall Clay BPres, CEOS - Sale$74.23-25,514636,632-4%-$1,893,950
2018-08-27
SGENLiu Jean IGC, EVP, Leg AffairsS - Sale$74.23-4,12356,741-7%-$306,058
2018-08-27
SGENHimes Vaughn BChief Technical OfficerS - Sale$74.23-5,530159,376-3%-$410,502
2018-08-27
SGENCline Darren SEVP, CommercialS - Sale$74.23-4,78465,079-7%-$355,125
2018-08-21
SGENSiegall Clay BPres, CEOS - Sale$74.95-25,000662,146-4%-$1,873,750
D
2018-08-09
SGENSiegall Clay BSee RemarksS - Sale+OE$72.71-18,831687,146-3%-$1,369,153
2018-07-31
SGENLippman Marc EDirS - Sale$69.25-7,400128,350-5%-$512,450
D
2018-07-09
SGENSiegall Clay BPres, CEOS - Sale+OE$69.07-18,832687,146-3%-$1,300,770
D
2018-06-12
SGENCline Darren SEVP, CommercialS - Sale+OE$69.00-12,05469,863-15%-$831,688
D
2018-06-08
SGENSiegall Clay BPres, CEOS - Sale+OE$65.12-18,832687,146-3%-$1,226,341
D
2018-05-31
SGENHimes Vaughn BChief Technical OfficerS - Sale+OE$58.47-5,000164,906-3%-$292,365
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top